Bioinformatics company SomaLogic partnered with Dante Genomics, a global leader in genomics and precision medicine, to offer a comprehensive proteomics testing solution in Europe. Dante became the first authorized site in Italy for SomaLogic's technology.
The partnership aims to combine proteomics and genomics to enhance the research and discovery capabilities of the proteome. Dante Genomics will run SomaLogic's 7,000-plex SomaScan platform in its Italian laboratory, providing proteomics services for the European market. The collaboration will enable multiomic capabilities to support clinical research discovery, expanding the databases and market reach for both companies.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.